SOFWAVE MEDICAL LTD.

Press Releases SofWave Medical Ltd.

Equities

SOFW

IL0011754392

Market Closed - TEL AVIV STOCK EXCHANGE Other stock markets 10:24:13 2024-06-10 am EDT			5-day change	1st Jan Change
1,728 ^ILa	+0.70%		+1.95%	+25.95%

May. 09	SofWave Medical Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
Mar. 06	SofWave Medical Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Sofwave Medical Receives Marketing Clearance in Canada for Pure Impact™ Strength and Muscle Toning Device	Jun. 11	AQ
Sofwave Medical Reports First Quarter 2024 Financial Results and Business Highlights	May. 09	AQ
SofWave Medical : Presentation- Q1 2024 Summary-May 2024	May. 09	PU
Sofwave Medical to Participate in the Needham 23rd Annual Healthcare Conference	Mar. 28	AQ
Sofwave Medical Reports Fourth Quarter and Full Year 2023 Financial Results and Business Highlights	Mar. 06	AQ
SofWave Medical : Presentation- Investor Meeting-March 2024	Mar. 06	PU
Sofwave Medical to Present Pure Impact™ Strength and Muscle Toning Module’s First U.S. Industry Reveal at the 2024 American Academy of Dermatology (AAD) Annual Meeting	Mar. 04	AQ
Sofwave Medical to Participate in the Oppenheimer 34th Annual Healthcare MedTech & Services Conference	Feb. 28	AQ
Sofwave Medical Appoints Medical Aesthetics Industry Expert James Bartholomeusz to the Role of Chief Innovation Officer	Feb. 12	AQ
Sofwave Medical Receives 510(k) Marketing Clearance for Pure Impact™ Strength and Muscle Toning Body Module Utilizing PlyoPulse™ EMS Technology	Jan. 03	AQ
Sofwave Medical Receives FDA Clearance of SUPERB™ Technology For Improvement of the Appearance of Skin Laxity on the Upper Arm	Dec. 26	AQ
Sofwave Earns Frost & Sullivan's 2023 North American Technology Innovation Leadership Award for Developing a Sophisticated Skin Tightening Ultrasound Technology with Minimal Downtime	Nov. 20	AQ
Sofwave Medical Reports Third Quarter 2023 Financial Results and Business Highlights	Nov. 08	AQ
Sofwave Medical Announces FDA Clearance of SUPERB™ Technology For Treatment of Acne Scars	23-08-30	AQ
Sofwave Medical Reports Second Quarter and First Half 2023 Financial Results and Recent Business Highlights	23-08-08	AQ
SofWave Medical : Presentation -August 2023	23-08-08	PU
Sofwave™ Gains Additional U.S. Patent Protection For the Company’s Proprietary SUPERB™ Technology	23-07-05	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

+39.41% on our US portfolio vs. 25.67% on the S&P 500 net Total Return

Replicate our performance

fermer